Immunotherapy for Advanced Liver Cancer

Clinical trial NCT05033522 · SUSPENDED

Trial details

NCT number: NCT05033522
Sponsor: Mirror Biologics, Inc.
Status: SUSPENDED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2023-08-01
Primary completion: 2026-11-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.